Elicio Therapeutics, Inc. (ELTX) NASDAQ
12.20
+1.3(+11.93%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
12.20
+1.3(+11.93%)
Currency In USD
| Market Cap | 121.89M |
| Enterprise Value | 108.43M |
| P/E Ratio | -4.72 |
| PEG Ratio | -0.22 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 114.19 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -5.05 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.53 |
| Return On Equity | -9.78 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -37.71M |
| Net Income | -39.57M |
| Diluted EPS | -2.58 |
| Total Cash | 18.56M |
| Total Cash/Share | 1.21 |
| Total Debt | 5.11M |
| Total Debt/Equity | 3.12 |
| Current Ratio | 2.38 |
| Book Value Per Share | 0.11 |
| 52-Week Change | 57.42 |
| 52-Week High | 14.93 |
| 52-Week Low | 4.6 |
| Moving Average 50 Days | 9.19 |
| Moving Average 200 Days | 9.29 |
| Average Volume | 129,158 |
| Shares Outstanding | 17.26M |
| % Held by Institutions | 12.46 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | June 02, 2023 |